Effects of moderate red wine consumption on liver fat and blood lipids: a prospective randomized study

References

• Corrao G, Rubbiati L, Bagnardi V, Zambon A, Poikolainen K. Alcohol and coronary heart disease: a meta-analysis. Addiction. 2000;95:1505–23.
   PubMed Web of Science ®Google Scholar
• Reaven GM. The metabolic syndrome: requiescat in pace. Clin Chem. 2005;51:931–8.
   PubMed Web of Science ®Google Scholar
• Gottrand F, Beghin L, Duhal N, Lacroix B, Bonte JP, Fruchart JC, . Moderate red wine consumption in healthy volunteers reduced plasma clearance of apolipoprotein AII. Eur J Clin Invest. 1999;29:387–94.
   PubMed Web of Science ®Google Scholar
• Naissides M, Mamo JC, James AP, Pal S. The effect of chronic consumption of red wine on cardiovascular disease risk factors in postmenopausal women. Atherosclerosis. 2006;185:438–45.
   PubMed Web of Science ®Google Scholar
• Napoli R, Cozzolino D, Guardasole V, Angelini V, Zarra E, Matarazzo M, . Red wine consumption improves insulin resistance but not endothelial function in type 2 diabetic patients. Metabolism. 2005;54:306–13.
   PubMed Web of Science ®Google Scholar
• Szczepaniak LS, Nurenberg P, Leonard D, Browning JD, Reingold JS, Grundy S, . Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab. 2005;288:E462–8.
   PubMed Web of Science ®Google Scholar
• Gramenzi A, Caputo F, Biselli M, Kuria F, Loggi E, Andreone P, . Review article: alcoholic liver disease–pathophysiological aspects and risk factors. Aliment Pharmacol Ther. 2006;24:1151–61.
   PubMed Web of Science ®Google Scholar
• Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55:434–8.
   PubMed Web of Science ®Google Scholar
• Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, . Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37:917–23.
   PubMed Web of Science ®Google Scholar
• Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 2005;42:44–52.
   PubMed Web of Science ®Google Scholar
• Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, . Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387–95.
   PubMed Web of Science ®Google Scholar
• Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, . Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44:865–73.
   PubMed Web of Science ®Google Scholar
• Dam-Larsen S, Franzmann M, Andersen IB, Christoffersen P, Jensen LB, Sorensen TI, . Long term prognosis of fatty liver: risk of chronic liver disease and death. Gut. 2004;53:750–5.
   PubMed Web of Science ®Google Scholar
• Garcia-Monzon C, Martin-Perez E, Iacono OL, Fernandez-Bermejo M, Majano PL, Apolinario A, . Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol. 2000;33: 716–24.
   PubMed Web of Science ®Google Scholar
• Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol. 2010;53: 372–84.
   PubMed Web of Science ®Google Scholar
• Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006;43:S99–S112.
   PubMed Web of Science ®Google Scholar
• Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998;158:1789–95.
   PubMed Web of Science ®Google Scholar
• Kechagias S, Ernersson A, Dahlqvist O, Lundberg P, Lindstrom T, Nystrom FH. Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects. Gut. 2008;57: 649–54.
   PubMed Web of Science ®Google Scholar
• Naressi A, Couturier C, Devos JM, Janssen M, Mangeat C, de Beer R, . Java-based graphical user interface for the MRUI quantitation package. MAGMA. 2001;12:141–52.
   PubMedGoogle Scholar
• Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson. 1997; 129:35–43.
   PubMed Web of Science ®Google Scholar
• Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, . Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care. 2000;23:57–63.
   PubMed Web of Science ®Google Scholar
• Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, . Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402–10.
   PubMed Web of Science ®Google Scholar
• Becker U, Deis A, Sorensen TI, Gronbaek M, Borch-Johnsen K, Muller CF, . Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology. 1996;23:1025–9.
   PubMed Web of Science ®Google Scholar
• Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M, . Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut. 1997;41:845–50.
   PubMed Web of Science ®Google Scholar
• Norton R, Batey R, Dwyer T, MacMahon S. Alcohol consumption and the risk of alcohol related cirrhosis in women. Br Med J (Clin Res Ed). 1987;295:80–2.
   PubMed Web of Science ®Google Scholar
• Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, . The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123: 745–50.
   PubMed Web of Science ®Google Scholar
• Thun MJ, Peto R, Lopez AD, Monaco JH, Henley SJ, Heath CW, Jr., . Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med. 1997;337:1705–14.
   PubMed Web of Science ®Google Scholar
• Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, . Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 2000;132:112–17.
   PubMed Web of Science ®Google Scholar
• Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, . Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology. 2008;48:792–8.
   PubMed Web of Science ®Google Scholar
• Retterstol L, Berge KE, Braaten O, Eikvar L, Pedersen TR, Sandvik L. A daily glass of red wine: does it affect markers of inflammation? Alcohol Alcohol. 2005;40:102–5.
   PubMed Web of Science ®Google Scholar
• Alatalo P, Koivisto H, Puukka K, Hietala J, Anttila P, Bloigu R, . Biomarkers of liver status in heavy drinkers, moderate drinkers and abstainers. Alcohol Alcohol. 2009;44: 199–203.
   PubMed Web of Science ®Google Scholar
• Tyulina OV, Prokopieva VD, Boldyrev AA, Johnson P. Erythrocyte and plasma protein modification in alcoholism: a possible role of acetaldehyde. Biochim Biophys Acta. 2006;1762:558–63.
   PubMed Web of Science ®Google Scholar
• Ohtake H, Kato S, Murawaki Y, Kishimoto Y, Wakushima T, Hirayama C. Acute and chronic effect of ethanol on hepatic albumin synthesis in rat liver in vitro. Res Commun Chem Pathol Pharmacol. 1986;53:213–31.
   PubMedGoogle Scholar
• Rothschild MA, Oratz M, Schreiber SS. Serum albumin. Hepatology. 1988;8:385–401.
   PubMed Web of Science ®Google Scholar
• Schapiro RH, Scheig RL, Drummey GD, Mendelson JH, Isselbacher KJ. Effect of prolonged ethanol ingestion on the transport and metabolism of lipids in man. N Engl J Med. 1965;272:610–5.
   PubMed Web of Science ®Google Scholar
• Belfrage P, Berg B, Cronholm T, Elmqvist D, Hagerstrand I, Johansson B, . Prolonged administration of ethanol to young, healthy volunteers: effects on biochemical, morphological and neurophysiological parameters. Acta Med Scand Suppl. 1973;552:1–44.
   PubMedGoogle Scholar
• Johnson NA, Sachinwalla T, Walton DW, Smith K, Armstrong A, Thompson MW, . Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology. 2009;50:1105–12.
   PubMed Web of Science ®Google Scholar
• Kawano Y. Physio-pathological effects of alcohol on the cardiovascular system: its role in hypertension and cardiovascular disease. Hypertens Res. 2010;33:181–91.
   PubMed Web of Science ®Google Scholar
• Rouleau J. Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) trial. Am J Med. 2005; 118 Suppl 12A:28–35.
   Web of Science ®Google Scholar
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7–22.
   PubMed Web of Science ®Google Scholar
• Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, . Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet. 2005;366:1849–61.
   PubMed Web of Science ®Google Scholar
• Kastelein JJ, van Leuven SI, Burgess L, Evans GW, Kuivenhoven JA, Barter PJ, . Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N Engl J Med. 2007;356:1620–30.
   PubMed Web of Science ®Google Scholar
• Lof M, Forsum E. Validation of energy intake by dietary recall against different methods to assess energy expenditure. J Hum Nutr Diet. 2004;17:471–80.
   PubMed Web of Science ®Google Scholar
• Renaud S, de Lorgeril M, Delaye J, Guidollet J, Jacquard F, Mamelle N, . Cretan Mediterranean diet for prevention of coronary heart disease. Am J Clin Nutr. 1995;61: 1360S–1367S.
   PubMed Web of Science ®Google Scholar
• Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, . Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008;359: 229–41.
   PubMed Web of Science ®Google Scholar
• Marfella R, Cacciapuoti F, Siniscalchi M, Sasso FC, Marchese F, Cinone F, . Effect of moderate red wine intake on cardiac prognosis after recent acute myocardial infarction of subjects with Type 2 diabetes mellitus. Diabet Med. 2006;23:974–81.
   PubMed Web of Science ®Google Scholar